MGC Pharmaceuticals (MXC)
MGC Pharmaceuticals Ltd. engages in the production of medical marijuana. Its Endocannabinoid system covers all cells and nerves; it is the messenger of information flowing between immune system and the central nervous system. The company was founded on October 21, 2005 and is headquartered in Perth, Australia.
|Market Price at 17-11-2017||$0.07|
|Price to Earnings Ratio||-6.87|
|Market Capitalisation||$80.05 (million)|
|Return on Equity (ROE)||-40.73%|